U.S. Household Products Stock News

In late February 2026, BioCryst Pharmaceuticals reported fourth-quarter 2025 revenue of US$406.56 million and net income of US$245.85 million, capping its first full year of profitability with US$874.84 million in revenue and US$263.86 million in net income. The move into sustained profitability, underpinned by strong ORLADEYO performance and the Astria Therapeutics acquisition that broadened its hereditary angioedema portfolio, marks a step-change in BioCryst’s financial and competitive...

In February 2026, Rackspace Technology reported fourth quarter 2025 revenue of US$682.8 million and a net loss of US$32.7 million, alongside full-year 2025 revenue of US$2.69 billion and a net loss of US$225.8 million, both narrower than the prior year. The company also issued 2026 revenue guidance of US$2.60 billion to US$2.70 billion, giving investors a clearer view of expected top-line stability while losses remain material. Next, we will examine how Rackspace’s narrower 2025 net loss and...

Pediatrix Medical Group (MD) has drawn investor attention after recent share performance, with the stock down about 7% over the past month and 17% over the past 3 months, despite positive 1 year and 3 year total returns. See our latest analysis for Pediatrix Medical Group. The recent 7% 1 month and 17% 3 month share price declines suggest fading near term momentum, even though the 1 year and 3 year total shareholder returns remain positive. This can reflect investors reassessing Pediatrix...

Houlihan Lokey filed an SEC prospectus supplement covering the resale of new Class A shares tied to recent acquisitions and performance milestones. The filing sets out how these newly issued shares can be resold by certain holders, clarifying the legal status of stock linked to completed deals. The move sheds light on how Houlihan Lokey structures equity based incentives for acquired teams and deal related performance. For you as an investor looking at NYSE:HLI, this filing provides an...

Belite Bio (BLTE) shares are under the spotlight after the company reported a fourth quarter net loss of US$25.32 million and a full year net loss of US$77.61 million, both above prior-year levels. See our latest analysis for Belite Bio. Despite the wider losses, Belite Bio’s share price has shown strong momentum, with a 26.16% 90 day share price return and a very large 1 year total shareholder return that sits near 5x. This may point to shifting expectations around its pipeline rather than...

Lineage (LINE) is back in focus after reporting fourth quarter and full year 2025 results, which included a swing to a Q4 profit and a sharply smaller annual net loss, catching investors’ attention. See our latest analysis for Lineage. At a share price of US$40.52, Lineage has seen a 5.8% 7 day share price return, a 13.5% 30 day share price return, and a 14.4% year to date share price return. However, its 1 year total shareholder return of a 29.3% decline shows that recent momentum is...

Why Qnity Electronics (Q) Is Back on Investors’ Radar Qnity Electronics (Q) has drawn fresh attention after reporting Q4 2025 results that topped analyst revenue and earnings expectations, rolling out a multi year productivity plan, and approving a US$500 million share repurchase program. See our latest analysis for Qnity Electronics. The strong Q4 surprise, fresh 2026 net sales guidance and new M&A ambitions have coincided with powerful momentum, with a 30 day share price return of 31.8% and...

Madison Square Garden Entertainment Corp. recently disclosed that a data breach discovered on or about December 16, 2025 exposed personal information via a vulnerability in Oracle’s eBusiness Suite, prompting legal investigations by Edelson Lechtzin LLP on behalf of affected individuals. Beyond potential legal and remediation costs, this incident puts the company’s data security and operational controls under scrutiny at a time when it relies heavily on customer trust for its live...

Astec Industries, Inc. has now reported its fourth-quarter and full-year 2025 results, with Q4 sales rising to US$400.6 million from US$359.0 million and full-year sales reaching US$1.41 billion, while net income increased to US$38.8 million for 2025 and the Board maintained a quarterly dividend of US$0.13 per share payable in March 2026. Despite Q4 net income easing year on year, the company delivered record quarterly and annual sales, beat analyst earnings and revenue expectations,...

Chemed Corporation recently reported fourth-quarter 2025 results showing net income of US$76.75 million and full-year 2025 net income of US$265.24 million, both lower than the prior year, alongside 2026 adjusted earnings guidance of US$23.25–US$24.25 per diluted share. Despite ongoing share repurchases totaling US$2.62 billion since 2011, investors focused on pressure in VITAS and Roto-Rooter margins, including Medicare Cap constraints and water-restoration write-offs. We’ll now examine how...

Tarsus Pharmaceuticals (TARS) recently reported full year 2025 results, with revenue of US$451.36 million and a net loss of US$66.42 million, and also filed a US$141.73 million shelf registration. See our latest analysis for Tarsus Pharmaceuticals. The latest earnings improvement and governance changes appear to sit behind a strong share price recovery, with a 30 day share price return of 17.01% and a one year total shareholder return of 76.78%. This is despite the year to date share price...

In February 2026, Copart, Inc. reported that its second-quarter revenue slipped to US$1,121.67 million from US$1,163.32 million a year earlier, with net income easing to US$350.73 million and diluted earnings per share from continuing operations at US$0.36 versus US$0.40. An interesting contrast is that while quarterly revenue and profit dipped year over year, Copart’s net income for the first half of the fiscal year edged up slightly to US$754.45 million, with earnings per share essentially...

QuidelOrtho (QDEL) has drawn fresh investor attention after announcing a long-term supply agreement with Lifotronic Technology, giving the diagnostics company access to additional immunoassay analyzers and more than 70 assays across select markets outside the United States. See our latest analysis for QuidelOrtho. That supply agreement arrives at a time when QuidelOrtho’s share price has seen a 7.31% 7 day gain to US$22.74, but its year to date share price return of 20.99% and 1 year total...

Earnings and leadership changes draw focus to Erie Indemnity (ERIE) Erie Indemnity (ERIE) has moved into the spotlight after releasing its full year 2025 results, showing revenue of US$4,067.26 million alongside lower net income and earnings per share compared with the prior year. See our latest analysis for Erie Indemnity. Investors have been weighing the full year 2025 results and the planned CEO transition against recent market performance, with the share price at US$269.44 and a 1 year...

Nucor Corporation’s board recently declared a regular quarterly cash dividend of US$0.56 per share, its 212th consecutive payout, and authorized a new US$4.00 billion share repurchase program after completing the prior US$3.69 billion buyback. The company also reshaped its senior leadership team by appointing John L. “Jack” Sullivan as Chief Financial Officer, Treasurer and Executive Vice President, following Steve Laxton’s earlier move to President and Chief Operating Officer. We’ll now...

Without a specific news headline driving attention, Belden (BDC) is drawing interest as investors look at its recent share performance, business profile, and current financial footprint in data infrastructure and industrial connectivity. See our latest analysis for Belden. Belden’s share price has pulled back 2.7% over the last day but still sits at US$143.30 after a strong 30 day share price return of 21.95% and a 1 year total shareholder return of 30.46%, which points to momentum that has...

Metropolitan Bank Holding Corp. recently completed a follow-on public offering of 2,100,000 common shares at US$85.00 each, raising about US$178.5 million to bolster capital and fund organic growth, technology investment, and general corporate purposes. The move meaningfully expands the bank’s equity base while supporting its post–Project Phoenix push into technology and AI-driven efficiency, reshaping how it finances future expansion. We’ll now examine how this sizeable equity raise, aimed...

Asbury Automotive Group recently completed the sale of ten dealerships, generating about US$210 million in net proceeds and expanding its authorized share repurchase program to US$500 million, while also exiting a Chrysler Dodge Jeep Ram store that was acquired and rebranded as Indy CDJR by Matt Bowers. Together, these moves highlight Asbury’s ongoing portfolio reshaping and its preference to return capital to shareholders rather than reinvest all proceeds into owned dealership...

Farmers National Banc recently drew heightened attention as a regional lender with a traditional community banking model centered on Ohio and nearby Midwest markets, where it is contending with margin pressure from higher deposit costs and slower loan repricing. What makes this situation especially important is the combination of rising credit risks in commercial real estate and small business portfolios with questions about how regulatory scrutiny and the interest‑rate backdrop could affect...

Cohen & Steers, Inc. recently declared a first-quarter 2026 cash dividend of US$0.67 per share, up from US$0.62 in the prior quarter, payable on March 19, 2026 to shareholders of record as of March 9, 2026. The 8.1% dividend increase highlights management’s willingness to return more cash to shareholders, which can be an important signal about the firm’s current capital position and confidence in its operations. We’ll now examine how this higher common-stock dividend, alongside the firm’s...

Why Empire State Realty Trust is back on investors’ radar Empire State Realty Trust (ESRT) has moved back into focus after fourth quarter 2025 results showed higher quarterly revenue and net income year over year, alongside fresh leasing wins with major tenants. For the fourth quarter, ESRT reported sales of US$159.72 million and revenue of US$199.22 million, compared with US$155.13 million and US$197.6 million a year earlier. Net income came in at US$20.73 million versus US$12.22 million,...

Fulgent Genetics (FLGT) is back on investors’ radar after its latest update, with 2025 earnings showing US$322.67 million in sales, a wider net loss, and fresh 2026 revenue guidance of about US$350 million. See our latest analysis for Fulgent Genetics. The share price reaction has been sharp, with a 1 day share price return of a 38.09% decline and a year to date share price return of a 40.09% decline, even though the 1 year total shareholder return is roughly flat. This suggests recent...

In February 2026, National Storage Affiliates Trust reported fourth-quarter 2025 results with revenue of US$187.03 million and net income of US$22.89 million, alongside full-year 2025 revenue of US$752.93 million and net income of US$73.78 million, and issued 2026 guidance that included diluted EPS of US$0.93 to US$1.03. Beyond the headline earnings beat, the company highlighted improving occupancy, sequential same-store revenue progress, and funds from operations above expectations, while...

Safety Insurance Group, Inc. reported past full-year 2025 results, with revenue of US$1,263.73 million and net income of US$99.26 million, alongside fourth-quarter net income of US$20.1 million on revenue of US$319.3 million. The company paired these stronger earnings with shareholder-focused actions, including repurchasing US$20 million of stock in the fourth quarter and approving a US$0.92 per-share quarterly dividend payable in March 2026. We’ll now examine how the combination of improved...